Voyager Therapeutics (VYGR) Preferred Dividend Payments (2014 - 2015)
Voyager Therapeutics' (VYGR) quarterly Preferred Dividend Payments came in at -$4.8 million in Q4 2015, down 1046.75% year-on-year from $507000.0 in Q4 2014, and down 285.04% quarter-over-quarter from $2.6 million in Q3 2015.
Voyager Therapeutics (VYGR) Preferred Dividend Payments (2014 - 2015) Analysis & Trends
Voyager Therapeutics has disclosed Preferred Dividend Payments across 2 years of filings, most recently posting -$4.8 million for Q4 2015.
- Preferred Dividend Payments for Q4 2015 came in at -$4.8 million, down 1046.75% year-over-year; the trailing twelve-month figure through Dec 2015 was $483000.0 (changed N/A YoY), and the FY2016 annual result was $1.2 million, down 3.61% from the prior year.
- Preferred Dividend Payments came in at -$4.8 million for Q4 2015 at Voyager Therapeutics, down from $2.6 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $2.6 million in Q3 2015 to a low of -$4.8 million in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Voyager Therapeutics | 222.52 Mn | 81.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -4.80 Mn |
| Sep 30, 2015 | 2.59 Mn |
| Jun 30, 2015 | 2.45 Mn |
| Mar 31, 2015 | 237,000.00 |
| Dec 31, 2014 | 507,000.00 |
| Sep 30, 2014 | 406,000.00 |